Quick Answer
NUTRA PHARMA CORP reported Net Income of -$1.29 million for fiscal year 2024.
NUTRA PHARMA CORP Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$1.29M | +7.7% |
| 2023 | -$1.39M | -117.0% |
| 2022 | $8.18M | +162.4% |
| 2021 | -$13.10M | -1602.5% |
| 2020 | -$769.2K | +88.3% |
| 2019 | -$6.59M | -69.7% |
| 2018 | -$3.88M | +3.6% |
| 2017 | -$4.03M | -16.9% |
| 2016 | -$3.45M | +36.1% |
| 2015 | -$5.39M | -112.9% |
| 2014 | -$2.53M | +41.7% |
| 2013 | -$4.34M | -20.2% |
| 2012 | -$3.61M | +17.8% |
| 2011 | -$4.40M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | $369.6K | +200.7% | +241.8% |
| September 30, 2024 | -$260.7K | +6.4% | +29.0% |
| June 30, 2024 | -$367.1K | -31.5% | +14.0% |
| March 31, 2024 | -$426.9K | +28.0% | -53.3% |
| September 30, 2023 | -$278.5K | -148.2% | +0.3% |
| June 30, 2023 | -$279.2K | +56.8% | +52.9% |
| March 31, 2023 | -$592.6K | -111.8% | -202.7% |
| September 30, 2022 | $577.2K | -96.3% | +189.4% |
- NUTRA PHARMA CORP showed an increase of +7.7% in Net Income compared to the prior fiscal year.
- Over the 2011–2024 period, NUTRA PHARMA CORP’s net income has grown by 70.8% (from -$4.40 million to -$1.29 million).
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: